Ashok Muniappan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashok Muniappan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Lida P. Hariri
Massachusetts General Hospital Department of Pathology and Division of Pulmonary and Critical Care Medicine . Boston, MA
3 shared publications - Michael Lanuti
Division of Thoracic Surgery, Massachusetts General Hospital, Boston, Mass
3 shared publications - Sreyankar Nandy
Division of Pulmonary and Critical Care Medicine
3 shared publications - Ankur M. Sharma
Radiology, Massachusetts General Hospital, Boston, MA, United States
2 shared publications B.W. Roop
Department of Medicine, Pulmonary and Critical Care Division, Massachusetts General Hospital, Boston, MA, United States
2 shared publications- Harald Christian Ott
Division of Thoracic Surgery, Massachusetts General Hospital, Boston, MA, USA
2 shared publications
Latest Publications
- 1 February 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 223 (2) , 404-409
Risk factors for recurrent spontaneous pneumothorax: A population level analysis
- 1 February 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 223 (2) , 404-409
Risk factors for recurrent spontaneous pneumothorax: A population level analysis
- 1 February 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 113 (2) , 406-412
Evaluation of Release Maneuvers After Airway Reconstruction
- 1 February 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 113 (2) , 406-412
Evaluation of Release Maneuvers After Airway Reconstruction
- Open Access
- 26 April 2021
- Published by Springer Nature in Respiratory Research
- Vol. 22 (1) , 1-9
Practical application and validation of the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines for the diagnosis of idiopathic pulmonary fibrosis
Background: Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is essential to inform prognosis and treatment. In 2018, the ATS/ERS/JRS/ALAT and Fleischner Society released new diagnostic guidelines for usual interstitial pneumonitis (UIP)/IPF, adding Probable UIP as a CT category based on prior studies demonstrating this category had relatively high positive predictive value (PPV) for histopathologic UIP/Probable UIP. This study applies the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines to determine test characteristics of CT categories in academic clinical practice. Methods: CT and histopathology were evaluated by three thoracic radiologists and two thoracic pathologists. Comparison of consensus categorization by the 2018 ATS and Fleischner Society guidelines by CT and histopathology was performed. Results: Of patients with CT UIP, 87% (PPV, 95% CI: 60–98%) had histopathologic UIP with 97% (CI: 90–100%) specificity. Of patients with CT Probable UIP, 38% (PPV, CI: 14–68%) had histopathologic UIP and 46% (PPV, CI: 19–75%) had either histopathologic UIP or Probable UIP, with 88% (CI: 77–95%) specificity. Patients with CT Indeterminate and Alternative Diagnosis had histopathologic UIP in 27% (PPV, CI: 6–61%) and 21% (PPV, CI: 11–33%) of cases with specificities of 90% (CI: 80–96%) and 25% (CI: 16–37%). Interobserver variability (kappa) between radiologists ranged 0.32–0.81. Conclusions: CT UIP and Probable UIP have high specificity for histopathologic UIP, and CT UIP has high PPV for histopathologic UIP. PPV of CT Probable UIP was 46% for combined histopathologic UIP/Probable UIP. Our results indicate that additional studies are needed to further assess and refine the guideline criteria to improve classification performance.
- 26 April 2021
- Published by Springer Nature in Respiratory Research
- Vol. 22 (1) , 1-9
Open AccessPractical application and validation of the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines for the diagnosis of idiopathic pulmonary fibrosis
Background: Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is essential to inform prognosis and treatment. In 2018, the ATS/ERS/JRS/ALAT and Fleischner Society released new diagnostic guidelines for usual interstitial pneumonitis (UIP)/IPF, adding Probable UIP as a CT category based on prior studies demonstrating this category had relatively high positive predictive value (PPV) for histopathologic UIP/Probable UIP. This study applies the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines to determine test characteristics of CT categories in academic clinical practice. Methods: CT and histopathology were evaluated by three thoracic radiologists and two thoracic pathologists. Comparison of consensus categorization by the 2018 ATS and Fleischner Society guidelines by CT and histopathology was performed. Results: Of patients with CT UIP, 87% (PPV, 95% CI: 60–98%) had histopathologic UIP with 97% (CI: 90–100%) specificity. Of patients with CT Probable UIP, 38% (PPV, CI: 14–68%) had histopathologic UIP and 46% (PPV, CI: 19–75%) had either histopathologic UIP or Probable UIP, with 88% (CI: 77–95%) specificity. Patients with CT Indeterminate and Alternative Diagnosis had histopathologic UIP in 27% (PPV, CI: 6–61%) and 21% (PPV, CI: 11–33%) of cases with specificities of 90% (CI: 80–96%) and 25% (CI: 16–37%). Interobserver variability (kappa) between radiologists ranged 0.32–0.81. Conclusions: CT UIP and Probable UIP have high specificity for histopathologic UIP, and CT UIP has high PPV for histopathologic UIP. PPV of CT Probable UIP was 46% for combined histopathologic UIP/Probable UIP. Our results indicate that additional studies are needed to further assess and refine the guideline criteria to improve classification performance.
- 22 August 2005
- Published by Springer Nature
- p. 283-285
Die Kombinationen von Donor-spezifischen Transfusionen mit Cyclosporin A oder Rapamycin haben unterschiedliche Effekte auf die Toleranzinduktion für kardiale Allotransplantate und die Entstehung kardialer Allograftvaskulopathie im Miniaturschweinmodell
- 22 August 2005
- Published by Springer Nature
- p. 283-285
Die Kombinationen von Donor-spezifischen Transfusionen mit Cyclosporin A oder Rapamycin haben unterschiedliche Effekte auf die Toleranzinduktion für kardiale Allotransplantate und die Entstehung kardialer Allograftvaskulopathie im Miniaturschweinmodell